Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Andrea Ardizzoni, Luigi Cavanna et al.|British Journal of Cancer|2020Cited by 25
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Andrea Ardizzoni, Marcello Tiseo et al.|British Journal of Cancer|2021Cited by 0